Singulex, Inc.’s Erenna® Single Molecule Counting Technology an Enabling Factor in Two Award Winning Studies Presented at the AACC Annual Meeting
7/31/2013 10:07:43 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Singulex, Inc., first to commercialize Single Molecule Counting (SMC) technology and committed to improving patient care and enabling the reduction of healthcare costs by providing high-value, advanced tests and systems for the diagnosis and monitoring of chronic diseases, today announced that the AACC has recognized two studies featuring Singulex’s Erenna® technology with the National Academy of Clinical Biochemistry’s Distinguished Abstract Award at its Annual Meeting being held in Houston, TX.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by